24 Fanconi Anemia Clinical Trials in San Francisco, CA (2026)

Q: How do I join a clinical trial in San Francisco?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the San Francisco research site will contact you.

Recruiting Fanconi Anemia Studies in San Francisco

NCT05701358Recruiting

Physiology-guided vs Angiography-guided Non-culprit Lesion Complete Revascularization for Acute MI & Multivessel Disease

COMPLETE-2 is a prospective, multi-centre, randomized controlled trial comparing a strategy of physiology-guided complete revascularization to angiography-guided complete revascularization in patients...

San Francisco, CA5,100 participantsPopulation Health Research Institute

View Study Details

NCT04077762Recruiting

Radial Vs. State-Of-The-Art Femoral Access for Bleeding and Access Site Complication Reduction in Cardiac Catheterization (REBIRTH)

This is a phase IV, prospective, open label, randomized-controlled study that will compare radial access with state-of-the-art femoral access in patients without ST-segment elevation acute myocardial ...

San Francisco, CA3,266 participantsMinneapolis Heart Institute Foundation

View Study Details

NCT06033950Recruiting

A Study to Evaluate Finerenone on Clinical Efficacy and Safety in Patients with Heart Failure Who Are Intolerant or Not Eligible for Treatment with Steroidal Mineralocorticoid Receptor Antagonists

Finerenone will be compared to placebo to determine efficacy and safety of treatment in patients with heart failure and reduced ejection fraction (HFrEF) who are intolerant or ineligible to receive tr...

San Francisco, CA2,600 participantsColorado Prevention Center

View Study Details

NCT05934487Recruiting

PROACTIVE-HF-2 Trial Heart Failure NYHA Class II and III

This is a prospective, multi-center, open label, randomized control clinical trial evaluating the safety and efficacy of the Cordella™ Pulmonary Artery Sensor System in NYHA Class II-III Heart Failure...

San Francisco, CA1,750 participantsEndotronix, Inc.

View Study Details

NCT06526195Recruiting

Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure

The purpose of TEAM-HF IDE clinical trial is to evaluate safety and effectiveness of the HeartMate 3 LVAS compared to guideline directed medical therapy (GDMT) in a population of ambulatory advanced h...

San Francisco, CA850 participantsAbbott Medical Devices

View Study Details

NCT06678841Recruiting

ELEVATE-HFpEF Clinical Study

ELEVATE-HFpEF is a prospective, randomized, controlled, double-blinded, multi-center, global, interventional pivotal study evaluating the safety and efficacy of dual chamber personalized pacing compar...

San Francisco, CA700 participantsMedtronic Cardiac Rhythm and Heart Failure

View Study Details

NCT07084142Recruiting

Developing a Digital Aid to Improve ICD Decisions

Advanced heart failure, affecting 7 million Americans, has multiple causes and results in greatly increased risk of disability and death. A major problem is sudden cardiac death, when the damaged hear...

San Francisco, CA600 participantsStanford University

View Study Details

NCT05933083Recruiting

MCNAIR Study: coMparative effeCtiveness of iN-person and teleheAlth cardIac Rehabilitation

Cardiac rehabilitation is a medically recommended program for patients with certain heart conditions. It includes exercise training, health education, and counseling. Unfortunately, many patients do n...

San Francisco, CA516 participantsUniversity of California, San Francisco

View Study Details

NCT06378632Recruiting

AN INTERNATIONAL, OBSERVATIONAL, BLINDED STUDY TO ASSESS THE PERFORMANCE OF THE CORDIO HEARO SYSTEM

Study Design: This is an international, multicenter, observational, non-interventional, prospective, blinded, single-arm, two-period study, to collect patient utterances that will be retrospectively ...

San Francisco, CA500 participantsCordio Medical

View Study Details

NCT05677100Recruiting

Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure

Aortix is a circulatory support device for chronic heart failure patients on medical management who have been hospitalized for acute decompensated heart failure (ADHF) and have persistent congestion d...

San Francisco, CA320 participantsProcyrion

View Study Details

NCT07227441Recruiting

Chronic Infections and Inflammation in ME/CFS: An Observational Study

CHIIME is a study of people who have myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). People who do not have this condition will also be enrolled. Volunteers will be observed and sampled o...

San Francisco, CA200 participantsUniversity of California, San Francisco

View Study Details

NCT06979362Recruiting

A Research Study Comparing Different Doses of CDR132L With Placebo on the Structure and Function of the Heart in People With Heart Failure With Preserved Ejection Fraction and Left Ventricular Hypertrophy

This study will look into how CDR132L (a potential new medicine) works on the structure and function of the heart in people living with heart failure. Participants will either get CDR132L or placebo (...

San Francisco, CA200 participantsNovo Nordisk A/S

View Study Details

NCT04862221Recruiting

TReatment for ImmUne Mediated PathopHysiology

TReatment for ImmUne Mediated PathopHysiology (TRIUMPH) is a multi-center, three arm, randomized, controlled trial of immunosuppressive therapy for children with acute liver failure. The study will de...

San Francisco, CA163 participantsNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

View Study Details

NCT06317662Recruiting

Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia

This phase II trial tests the addition of venetoclax and/or blinatumomab to usual chemotherapy for treating infants with newly diagnosed acute lymphoblastic leukemia (ALL) with a KMT2A gene rearrangem...

San Francisco, CA153 participantsNational Cancer Institute (NCI)

View Study Details

NCT04592445Recruiting

Endovascular Ablation of the Right Greater Splanchnic Nerve in Subjects Having HFpEF

The purpose of this clinical study is to evaluate the safety and early effectiveness of a catheter-based procedure that treats a nerve called the right greater splanchnic nerve. The study includes peo...

San Francisco, CA150 participantsAxon Therapies, Inc.

View Study Details

NCT05034432Recruiting

The PIVATAL Study -Study of Ventricular Arrhythmia (VTA) Ablation in Left Ventricular Assist Device (LVAD) Patients

To investigate the effect of VTA ablation at the time of LVAD implant to see if it can reduce the incidence of VTA after surgery...

San Francisco, CA100 participantsUniversity of Rochester

View Study Details

NCT06428097Recruiting

Levothyroxine Supplementation for Heart Transplant Recipients

This will be a prospective, randomized study performed at a single tertiary referral academic medical center (University of California San Francisco, CA), evaluating the survival benefits of levothyro...

San Francisco, CA97 participantsUniversity of California, San Francisco

View Study Details

NCT06753916Recruiting

ExCrossV Multi Site Trial for Vascularized High Risk Keratoplasty

The main objective of this study is to determine the safety of Ex Vivo Cross Linking (CXL) of donor corneal tissue in participants who have undergone high-risk penetrating keratoplasty....

San Francisco, CA96 participantsMassachusetts Eye and Ear Infirmary

View Study Details

NCT07443670Recruiting

Voice Analysis to Detect Pulmonary Arterial Pressure Changes in Heart Failure

VAPP-HF is a prospective, multi-center, observational study assessing whether daily voice recordings analyzed by a machine learning algorithm can detect changes in pulmonary arterial (PA) pressure in ...

San Francisco, CA60 participantsNoah Labs

View Study Details

NCT06793371Recruiting

AMBER-HFpEF: Assessment of CK-4021586 in a Multi-Center, Blinded Evaluation of Safety and Tolerability Results in HFpEF

This is a Phase 2 dose-finding study in adult participants with symptomatic HFpEF....

San Francisco, CA60 participantsCytokinetics

View Study Details

NCT07335510Recruiting

Impact of Barostimulation on Hemodynamics in Adults With Heart Failure

This study evaluates the effects of the implantation and adjustment of the CVRx Barostim device in adult patients with heart failure with reduced ejection fraction who are receiving maximally tolerate...

San Francisco, CA58 participantsColumbia University

View Study Details

NCT04703842Recruiting

Modulation of SERCA2a of Intra-myocytic Calcium Trafficking in Heart Failure With Reduced Ejection Fraction

It is believed that targeted SERCA2a enzyme replacement in HFrEF patients will correct defective intracellular Ca2+ hemostasis, resulting in improved cardiac contractile function and energetics which ...

San Francisco, CA57 participantsSardocor Corp.

View Study Details

NCT06360380Recruiting

Reducing Fluid Overload in Heart Failure Patients Using a Non-invasive, Renal Independent System

The REFORM-HF study aims to test a new technology, AQUAPASS, designed to assist patients experiencing symptoms of fluid overload due to Heart Failure. Patients will wear a lightweight suit that helps...

San Francisco, CA40 participantsAquaPass Medical Ltd.

View Study Details

NCT05919680Recruiting

A Study of NST-6179 in Subjects With Intestinal Failure-Associated Liver Disease (IFALD).

This is a phase 2a, multicenter, randomized, double-blind, placebo-controlled study to evaluate the safety, tolerability, pharmacokinetics (PK), and pharmacodynamics (PD) of NST-6179 in subjects with ...

San Francisco, CA36 participantsNorthSea Therapeutics B.V.

View Study Details

About Fanconi Anemia Clinical Trials in San Francisco

Fanconi anemia is a rare genetic disorder that affects bone marrow, reducing production of all types of blood cells and increasing cancer susceptibility. It is associated with physical abnormalities and organ defects. Treatment includes blood transfusions, growth factors, and stem cell transplant.

There are currently 24 fanconi anemia clinical trials recruiting participants in San Francisco, CA. These studies are seeking a combined 17,672 participants. Research is being sponsored by Population Health Research Institute, Minneapolis Heart Institute Foundation, Colorado Prevention Center and 19 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Fanconi Anemia Clinical Trials in San Francisco — FAQ

Are there fanconi anemia clinical trials in San Francisco?

Yes, there are 24 fanconi anemia clinical trials currently recruiting in San Francisco, CA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in San Francisco?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the San Francisco research site will contact you about next steps.

Are clinical trials in San Francisco free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many San Francisco studies also compensate for your time and travel.

What fanconi anemia treatments are being tested?

The 24 active trials in San Francisco are testing new therapies including novel drugs, biologics, and treatment approaches for fanconi anemia.

Data updated July 13, 2026 from ClinicalTrials.gov